4.7 Article

Facile design of gemini surfactant-like peptide for hydrophobic drug delivery and antimicrobial activity

期刊

JOURNAL OF COLLOID AND INTERFACE SCIENCE
卷 591, 期 -, 页码 314-325

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.jcis.2021.02.019

关键词

Surfactant-like peptide; Gemini surfactant; Self-assembly; Antimicrobial activity; Hydrophobic drug

资金

  1. National Natural Science Foundation of China [81973274, 81000658]

向作者/读者索取更多资源

A simple strategy was proposed to design gemini surfactant-like peptides, and a peptide named APK was successfully designed with strong self-assembly and hydrophobic encapsulation capabilities. Furthermore, APK showed potential for anti-tumor, anesthetic, and antimicrobial applications.
Recently, many kinds of gemini-type amphiphilic peptides have been designed and shown their advantage as self-assembling nanomaterials. In this study, we proposed a simple strategy to design gemini surfactant-like peptides, which are only composed of natural amino acids and can be easily obtained by conventional peptide sythnesis. Taking two prolines as the turn-forming units, a peptide named APK was designed. The petide has a linear sequence but naturally takes the conformation like a gemini surfactant. Compared with a single-tailed surfactant-like peptide A6K, APK showed much stronger ability to undergo self-assembly and to encapsulate hydrophobic pyrene. Several hydrophobic drugs including paclitaxel, doxorubicin, etomidate and propofol were encapsulated by APK, and the corresponding formulations showed anti-tumor or anesthetic efficacy comparable to their respective clinical formulations. Furthermore, APK could inhibit the growth of different microorganisms including E. coli, S. aureus and C. albicans. Etomidate and propofol formulations encapsulated by APK also showed strong antimicrobial activity. Taking APK as an example, our study indicated a straightforward strategy to design gemini surfactant-like peptides, which could be potential nanomaterials for exploring hydrophobic drug formulations with efficacy, safety and self-antimicrobial activity. (c) 2021 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据